EMA Answers More Stakeholder Questions in Lead Up to EudraVigilance Launch

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency added answers to 60 new questions in its list of inquiries from stakeholders regarding the launch of its new EudraVigilance drug safety reporting program.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor